Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;23(2):277-285.
doi: 10.1038/s41391-019-0184-8. Epub 2019 Nov 6.

Prostate cancer characteristics and cancer-specific mortality of Native American patients

Marina Deuker  1   2 , Sophie Knipper  3   4 , Angela Pecoraro  3   5 , Carlotta Palumbo  3   6 , Giuseppe Rosiello  3   7 , Stefano Luzzago  3   8 , Zhe Tian  3 , Fred Saad  3 , Felix Chun  9 , Pierre I Karakiewicz  3
Affiliations

Prostate cancer characteristics and cancer-specific mortality of Native American patients

Marina Deuker et al. Prostate Cancer Prostatic Dis. 2020 Jun.

Abstract

Background: Historical epidemiological data indicate that Native American patients may have worse prostate cancer (PCa) characteristics than Caucasian patients (CAP). To test for cancer-specific mortality (CSM) differences among Native American vs. CAP, the most contemporary version of the SEER database (Surveillance, Epidemiology, and End Results database [2004-2016]) was used.

Methods: Descriptives and time trend analyses focused on a combined cohort of 357,289 Caucasian and Native American PCa patients of all stages. After 1:4 propensity-score (PS) matching for stage, grade, and other patient characteristics, cumulative incidence plots, and competing-risks-regression-models (CRR) were used, with further stratification according to non-metastatic (TanyN0M0) vs. metastatic (TanyN1 and/or M1) stages.

Results: Native American patients accounted for 1804 (0.5%) of the study cohort. Native American patients had higher PSA (8 ng/ml vs. 6.3 ng/ml), higher rate of D'Amico high-risk PCa (30.8 vs. 24.8%), higher rate of T3/T4-PCa (5.5 vs. 3.7%), higher rate of N1 stage (4.5 vs. 2.8%), and higher rate of M1 stage (7.5 vs. 3.9%, all p < 0.001) than CAP. In TanyN0M0 patients after PS-matching, 10-year CSM was 5.7 vs. 6.2% in Native American vs. CAP. In TanyN1 and/or M1 patients, 10-year CSM was 64.3 vs. 63.3% in Native American vs. CAP, (both p = 0.8). In CRR, Native American race did not represent an independent predictor of CSM.

Conclusions: Native American patients have more unfavorable stage and grade at presentation. However, after adjustment for these characteristics, CSM in Native American patients is not higher than in CAP. In consequence, PCa prognosis does not differ between Native American and Caucasian race. Therefore, efforts should be made to diagnose PCa in Native Americans at an earlier and more favorable stage like in CAP.

PubMed Disclaimer

References

    1. Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, et al. Annual Report to the Nation on the Status of Cancer, part i: national cancer statistics. Cancer. 2018;124:2785–800. - DOI
    1. Emerson MA, Banegas MP, Chawla N, Achacoso N, Alexeeff SE, Adams AS, et al. Disparities in prostate, lung, breast, and colorectal cancer survival and comorbidity status among Urban American Indians and Alaskan Natives. Cancer Res. 2017;77:6770–6. - DOI
    1. Espey DK, Jim MA, Cobb N, Bartholomew M, Becker T, Haverkamp D, et al. Leading causes of death and all-cause mortality in American Indians and Alaska Natives. Am J Public Health. 2014;104 Suppl 3:S303–11. - DOI
    1. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) program population-based study. Arch Intern Med. 2002;162:1985–93. - DOI
    1. Javid SH, Varghese TK, Morris AM, Porter MP, He H, Buchwald D, et al. Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients. Cancer. 2014;120:2183–90. - DOI

MeSH terms